NuCana Plc (NCNA)
0.9901
-0.03
(-2.93%)
USD |
NASDAQ |
Oct 16, 16:00
0.972
-0.02
(-1.83%)
After-Hours: 20:00
NuCana Cash from Investing (Quarterly) : -0.0453M for June 30, 2026
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0453M |
| March 31, 2026 | -0.1037M |
| December 31, 2025 | -0.0656M |
| September 30, 2025 | -0.0657M |
| June 30, 2025 | -0.0749M |
| March 31, 2025 | -0.0491M |
| December 31, 2024 | -0.0712M |
| September 30, 2024 | -0.0807M |
| June 30, 2024 | -0.1235M |
| March 31, 2024 | -0.1027M |
| December 31, 2023 | -0.1573M |
| September 30, 2023 | 3.144M |
| June 30, 2023 | -0.173M |
| March 31, 2023 | -0.1932M |
| December 31, 2022 | -0.1196M |
| September 30, 2022 | -0.1416M |
| June 30, 2022 | -0.1491M |
| Date | Value |
|---|---|
| March 31, 2022 | -0.2226M |
| December 31, 2021 | -0.6137M |
| September 30, 2021 | -3.920M |
| June 30, 2021 | -0.2999M |
| March 31, 2021 | -0.1958M |
| December 31, 2020 | -0.2955M |
| September 30, 2020 | -0.7665M |
| June 30, 2020 | -0.5081M |
| March 31, 2020 | -0.5213M |
| December 31, 2019 | -0.2906M |
| September 30, 2019 | -0.3186M |
| June 30, 2019 | -0.5964M |
| March 31, 2019 | -0.3881M |
| December 31, 2018 | -0.6531M |
| September 30, 2018 | -0.349M |
| June 30, 2018 | -0.7506M |
| March 31, 2018 | -0.4272M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| Mereo BioPharma Group Plc | -0.0004M |
| BioNTech SE | -118.82M |
| Silence Therapeutics Plc | 64.78M |
| Compass Pathways Plc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -2.571M |
| Cash from Financing (Quarterly) | 0.0685M |
| Free Cash Flow | -6.612M |
| Free Cash Flow Per Share (Quarterly) | -0.625 |
| Free Cash Flow to Equity (Quarterly) | -2.611M |
| Free Cash Flow to Firm (Quarterly) | -2.616M |
| Free Cash Flow Yield | -164.8% |